Research programme: sensor linked micelle therapeutics - NanoCarrier/TPG Biologics
Latest Information Update: 28 Apr 2021
At a glance
- Originator NanoCarrier; TPG Biologics
- Class Antibodies; Drug conjugates; Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Apr 2021 No recent reports of development identified for research development in Unspecified in Japan
- 28 Apr 2021 No recent reports of development identified for research development in Unspecified in Taiwan
- 05 Apr 2017 NanoCarrier and TPG Biologics enter research collaboration to develop Sensor linked micelle therapeutics